Artisan International Small-Mid Fund Q1 2024 Earnings Preview [Seeking Alpha]
Avidity Biosciences, Inc. (RNA)
Company Research
Source: Seeking Alpha
Our portfolio outperformed the MSCI ACWI ex US SMID Index in Q1, primarily due to our stock selection in health care. With the ongoing macroeconomic challenges and geopolitical uncertainties around the world, volatility remains elevated in both the equity and bond markets. Investing Environment Global equities advanced in Q1 primarily on investor expectations of central bank interest rate cuts in the US, EU and UK. However, the timing and magnitude of potential cuts are far from certain, as inflation remains above the Federal Reserve's 2% target and labor market strength persists. Macro dynamics, including volatility around interest rate expectations, continue to drive the markets against the backdrop of persistent inflation in the US and a sluggish economic recovery in China. In Japan, the central bank ended its negative rate regime after eight years and signaled it could raise rates further, although real rates are still in negative territory. In addition, volatility in forei
Show less
Read more
Impact Snapshot
Event Time:
RNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RNA alerts
High impacting Avidity Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RNA
News
- Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $40.00 price target on the stock.MarketBeat
- Strategies for Global Clinical Trials: Clinical Research Without Borders, Upcoming Webinar Hosted by XtalksPR Web
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- FYBR, BCRX and SABR are among after hour movers [Seeking Alpha]Seeking Alpha
- Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.MarketBeat
RNA
Earnings
- 2/28/24 - Miss
RNA
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- RNA's page on the SEC website